Table 1.
This table summarizes the detection of the mycotoxins in the urine of chronic fatigue syndrome (CFS) patients individually or in combinations. The ranges and averages are based upon the actual number of individual positives for each mycotoxin.
| Mycotoxin | Positive (N, %) | Range (ppb) | Average (ppb) |
|---|---|---|---|
| ATa | 13, 12% | 1.1–9.4 | 4.67 |
| OTAa | 87, 83% | 2–14.6 | 6.2 |
| MTa | 46, 44% | 0.21–5.72 | 0.85 |
| OTA + MT | 24, 23% | N/Ab | N/Ab |
| AT + MT | 4, 4% | N/Ab | N/Ab |
| AT, OTA, MT | 8, 8% | N/Ab | N/Ab |
a: Limits of Detection: AT (1 ppb); OTA (2.0 ppb); MT (0.2 ppb). b: N/A: Not applicable.